Leksell Vantage Stereotactic System, UDI/GTIN 7340048304887

FDA Device Recall #Z-2442-2020 — Class II — June 10, 2020

Recall Summary

Recall Number Z-2442-2020
Classification Class II — Moderate risk
Date Initiated June 10, 2020
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Elekta Instrument AB
Location Stockholm, N/A
Product Type Devices
Quantity 51 devices

Product Description

Leksell Vantage Stereotactic System, UDI/GTIN 7340048304887

Reason for Recall

The locking mechanism at the interface of the Instrument Carrier and the Leksell Vantage Arc may not function properly.

Distribution Pattern

MA, IL, NH, NC, UT, OH, FL, MN, TX, NY, LA, AZ, MT, WV, Austria, Croatia, Estonia, Finland, France, Germany, Hong Kong, India, Italy, Japan, Kuwait, Lithuania, Netherlands, Norway, Portugal, South Africa, Spain, Sweden, Switzerland, United Kingdom

Lot / Code Information

Serial numbers: SH00026, SH00049, SH00061, SH00082, SH00092, SH00111, SH00028, SH00050, SH00072, SH00084, SH00094, SH00118, SH00029, SH00052, SH00073, SH00085, SH00095, SH00121, SH00030, SH00054, SH00074, SH00086, SH00097, SH00123, SH00032, SH00055, SH00077, SH00087, SH00099, SH00127, SH00033, SH00057, SH00078, SH00088, SH00100, SH00162, SH00041, SH00058, SH00079, SH00089, SH00102, SH00044, SH00059, SH00080, SH00090, SH00105, SH00045, SH00060, SH00081, SH00091, SH00108

Other Recalls from Elekta Instrument AB

Recall # Classification Product Date
Z-0227-2025 Class I Elekta Disposable Biopsy Needle Kit for Leksell... Sep 25, 2024
Z-1397-2024 Class I Elekta Disposable Biopsy Needle Kit for Leksell... Mar 15, 2024
Z-1309-2023 Class II Instructions for Use for the following Leksell ... Mar 1, 2023
Z-1412-2019 Class II Leksell GammaPlan 11.1 Product Usage: Lekse... Jun 27, 2018

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.